Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Brusamolino, Ercole
36  Ergebnisse:
Personensuche X
?
1

Rituximab-dose-dense chemotherapy with or without high-dose..:

Chiappella, Annalisa ; Martelli, Maurizio ; Angelucci, Emanuele...
The Lancet Oncology.  18 (2017)  8 - p. 1076-1088 , 2017
Link: https://doi.org/10.1016/..
 
?
2

Bendamustine for Hodgkin lymphoma patients failing autologo..:

Anastasia, Antonella ; Carlo‐Stella, Carmelo ; Corradini, Paolo...
British Journal of Haematology.  166 (2014)  1 - p. 140-142 , 2014
Link: https://doi.org/10.1111/..
 
?
3

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LE..:

Fiaccadori, Valeria ; Gotti, Manuel ; Brusamolino, Ercole
Mediterranean Journal of Hematology and Infectious Diseases.  4 (2012)  1 - p. e2012022 , 2012
Link: https://doi.org/10.4084/..
 
?
4

Impact of treatment‐related liver toxicity on the outcome o..:

Arcaini, Luca ; Merli, Michele ; Passamonti, Francesco...
American Journal of Hematology.  85 (2009)  1 - p. 46-50 , 2009
Link: https://doi.org/10.1002/..
 
?
5

Rituximab Combined With MACOP-B or VACOP-B and Radiation Th..:

Zinzani, Pier Luigi ; Stefoni, Vittorio ; Finolezzi, Erica...
Clinical Lymphoma and Myeloma.  9 (2009)  5 - p. 381-385 , 2009
Link: https://doi.org/10.3816/..
 
?
6

Implications of the European Organisation for Research And ..:

Pettengell, Ruth ; Aapro, Matti ; Brusamolino, Ercole...
Clinical Drug Investigation.  29 (2009)  8 - p. 491-513 , 2009
Link: https://doi.org/10.2165/..
 
?
7

Managing the myelotoxicity of CHOP chemotherapy:

Brusamolino, Ercole
European Journal of Cancer Supplements.  6 (2008)  2 - p. 31-36 , 2008
Link: https://doi.org/10.1016/..
 
?
8

Development of a Richter syndrome with a monoclonal compone..:

Bernasconi, Paolo ; Paulli, Marco ; Orlandi, Ester...
Annals of Hematology.  86 (2007)  8 - p. 619-622 , 2007
Link: https://doi.org/10.1007/..
 
?
9

Correlation of the FLIPI score for follicular lymphoma with..:

Arcaini, Luca ; Colombo, Nora ; Passamonti, Francesco...
Leukemia Research.  30 (2006)  3 - p. 277-282 , 2006
Link: https://doi.org/10.1016/..
 
?
10

Nongastric Marginal-Zone B-Cell MALT Lymphoma: Prognostic V..:

Arcaini, Luca ; Burcheri, Sara ; Rossi, Andrea...
The Oncologist.  11 (2006)  3 - p. 285-291 , 2006
Link: https://doi.org/10.1634/..
 
?
11

Life expectancy and prognostic factors for survival in pati..:

Passamonti, Francesco ; Rumi, Elisa ; Pungolino, Ester...
The American Journal of Medicine.  117 (2004)  10 - p. 755-761 , 2004
Link: https://doi.org/10.1016/..
 
?
12

Combination of Rituximab, Cyclophosphamide, and Vincristine..:

Arcaini, Luca ; Orlandi, Ester ; Scotti, Monica...
Clinical Lymphoma.  4 (2004)  4 - p. 250-252 , 2004
Link: https://doi.org/10.3816/..
 
?
13

Long-term follow-up of young patients with essential thromb..:

Passamonti, Francesco ; Rumi, Elisa ; Malabarba, Lucia...
Annals of Hematology.  83 (2004)  8 - p. , 2004
Link: https://doi.org/10.1007/..
 
?
14

Splenic and nodal marginal zone lymphomas are indolent diso..:

Arcaini, Luca ; Paulli, Marco ; Boveri, Emanuela...
Cancer.  100 (2003)  1 - p. 107-115 , 2003
Link: https://doi.org/10.1002/..
 
?
15

Pipobroman is safe and effective treatment for patients wit..:

Passamonti, Francesco ; Malabarba, Lucia ; Orlandi, Ester...
British Journal of Haematology.  116 (2002)  4 - p. 855-861 , 2002
Link: https://doi.org/10.1046/..
 
1-15